MARKS PUBLISHED FOR OPPOSITION

JANUARY 11, 2005 U.S. PATENT AND TRADEMARK OFFICE TM 849
2,696,991. REG. 3-18-2003. LOVATO S.P.A. - COMPONENTI E
SISTEMI PER AUTOMAZIONE (ITALY JOINT STOCK
COMPANY) VIA BORFURO, 1, BERGAMO, ITALY,, SN
76-061,798. FILED 6-2-2000. PRINCIPAL REGISTER.
THE LINING IS A FEATURE OF THE MARK AND DOES
NOT INDICATE COLOR.
INT. CL. 9/U.S. CLS. 21, 23, 26, 36 AND 38
FOR ELECTROMECHANICAL AND ELECTRONIC
DEVICES AND COMPONENTS FOR ELECTRIC PA-
NELS, ELECTRIC INSTALLATIONS AND SYSTEMS,
AND FOR SAFETY APPLICATIONS, ALL THESE
GOODS NOT BEING FOR LPG AND CNG ENGINES,
NAMELY, PUSH-BUTTONS DESIGNED TO CLOSE OR
OPEN AN ELECTRIC CIRCUIT, SELECTORS FOR DI-
RECTING AN ELECTRIC CURRENT OR FOR MAKING
OR BREAKING A CIRCUIT, PILOT LIGHTS, WHICH,
USED IN ASSOCIATION WITH A CONTROL, INDICATE
THE FUNCTIONING OF THE CONTROL BY MEANS OF
POSITION OR COLOR, CONTROL STATIONS FOR
HOUSING A SET OF ONE OF THE FOLLOWING–
*PUSH-*BUTTONS, SELECTORS, OR PILOT LIGHTS,
USED TO OPERATE A PIECE OF EQUIPMENT OR TO
GIVE INDICATION, CONTACTORS, THERMAL OVER-
LOAD RELAYS, MOTOR PROTECTION RELAYS, ELEC-
TRONIC OVERLOAD RELAYS, SWITCH
DISCONNECTORS, FUSE DISCONNECTORS, THERMIS-
TOR PROTECTION RELAYS, CIRCUIT BREAKERS,
MINIATURE CIRCUIT BREAKERS, MOLDED-CASE
CIRCUIT [BROKERS,] *BREAKERS,* MANUAL MOTOR
STARTERS, DIRECT-ONLINE STARTERS, STAR-DELTA
STARTERS, AUTOMATIC STARTERS WITH STATOR
RESISTANCES, AUTOMATIC STARTERS WITH ROTOR
RESISTANCES, AUTOMATIC STARTERS WITH AUTO-
TRANSFORMER, MODULAR CONTACTORS, TIME RE-
LAYS, VOLTAGE RELAYS, CURRENT RELAYS, LEVEL
CONTROLS, STARTUP PRIORITY CHARGE RELAYS,
EARTH LEAKAGE RELAYS, SOFT STARTERS, AC
MOTOR DRIVES, AUTOMATIC POWER FACTOR REG-
ULATORS, AUTOMATIC BATTERY CHARGES, PRO-
GRAMMABLE CONTROLLERS, HOUR COUNTERS,
DIGITAL MULTIMETERS, CONTROL UNIT FOR GEN-
ERATING SETS, LIMIT SWITCHES, MEASURING IN-
STRUMENTS, MEASURING METERS,
PROGRAMMABLE LOGIC CONTROLS (PLC), ELEC-
TRIC PARAMETER ANALYZERS, ALL SOLD AS A
UNIT.
FIRST USE 4-6-1981; IN COMMERCE 4-30-1990.
ELEMENTS CORRECTED
GOODS/SERVICES
2,761,011. REG. 9-9-2003. AGRESEARCH LIMITED (NEW
ZEALAND COMPANY) EAST STREET, RUAKURA CAM-
PUS, HAMILTON, NEW ZEALAND,, SN 76-394,928. FILED
4-12-2002. PRINCIPAL REGISTER.
NICL-D
PRIORITY CLAIMED UNDER SEC. 44(D) ON NEW
ZEALAND APPLICATION NO. 649429, FILED 11-29-2001,
REG. NO. 649429, DATED 5-30-2002, EXPIRES 11-29-2008.
INT. CL. 9/U.S. CLS. 21, 23, 26, 36 AND 38
FOR MEASURING, CHECKING AND SCIENTIFIC
APPARATUS AND [INSTRUMENT] *INSTRUMENTS*,
NAMELY, SCANNERS FOR MEASURING THE FAT
CONTENT OF MEAT, DETERMINING CHEMICAL
LEANNESS OF MEAT, AND CHECKING FOR [CON-
TAINMENT] *CONTAMINANTS* IN MEAT.
FIRST USE ; IN COMMERCE .
ELEMENTS CORRECTED
GOODS/SERVICES
2,764,079. REG. 9-16-2003. UNIFUND CORPORATION LIM-
ITED (UNITED KINGDOM LIMITED PARTNERSHIP)
BRUSHFIELD STREET, 30-40 LONDON FRUIT EX-
CHANGE, LONDON, UNITED KINGDOM,, SN 76-
476,956. FILED 12-19-2002. PRINCIPAL REGISTER.
ALPHA PROGRAM
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "PROGRAM", APART FROM THE MARK AS SHOWN.
INT. CL. 5/U.S. CLS. 6, 18, 44, 46, 51 AND 52
FOR MEDICINAL PREPARATIONS IN THE FORM OF
POWDERS, CAPSULES, TABLETS, SALVES, OINT-
MENTS, OILS, SOLUTIONS, AND DROPS ALL USED
AS A NEURO-DEGENERATIVE INHIBITOR, NEURO-
ENDOCRINE MODULATOR, AND NEURO-CEREBRAL
METABOLISM ENHANCER FOR THE ELIMINATION
OF ANXIETY AND HYPERACTIVITY, MITIGATION OF
PANIC SYMPTOMOLOGY, REDUCTION OF FATIGUE,
IMPROVEMENT OF SELF-CONFIDENCE AND SELF-
ESTEEM, ELIMINATION OF THE NEED FOR ANTI-
DEPRESSANTS, COGNITIVE ENHANCEMENT, IM-
PROVEMENT OF AEROBIC ENDURANCE AND PER-
FORMANCE AND WEIGHT-TRAINING CAPACITY,
IMPROVEMENT OF BLOOD CIRCULATION, REDUC-
TION OF BLOOD PRESSURE AND HYPERTENSION,
IMPROVEMENT OF SEXUAL PERFORMANCE AND
LIBIDO, REDUCTION OF HORMONAL IMBALANCE
IN MENOPAUSAL AND POST-MENOPAUSAL WOMEN,
IMPROVEMENT OF VISUAL AND AUDITORY ACUITY,
IMPROVEMENT OF PHYSICAL AGILITY AND MUSCLE
FLEXIBILITY, IMPROVEMENT OF SOCIAL INTERAC-
TION SKILLS, PROMOTION OF RELAXATION RE-
SPONSE AND MITIGATION OF CHRONIC SLEEP
PATTERN DISORDERS SUCH AS INSOMNIA AND
OTHER CHRONIC SLEEP DISORDERS, REDUCTION
OF ARTHRITIC PAIN AND SWELLING, ENHANCE-
MENT OF IMMUNE SYSTEM FUNCTIONING, IM-
PROVEMENT OF THE METABOLISM, RELIEF FROM
CONSTIPATION, IMPROVEMENT OF SKIN TONE, MI-
TIGATION OF "JET LAG," AND REDUCTION IN
CAFFEINE DEPENDENCE; AND THE TREATMENT OF
A BROAD SPECTRUM OF CONDITIONS AND PATHOL-
OGIES, NAMELY, AGE-RELATED AND NEURO-DE-
GENERATIVE CONDITIONS AND PATHOLOGIES,
NERVE DISEASES, GENERAL ANXIETY DISORDER,
DEPRESSION, NEUROSIS, NEURASTHENIA, OBSES-
SIVE-COMPULSIVE DISORDER, CHRONIC SLEEP DIS-
ORDER, CHRONIC FATIGUE SYNDROME, DIGESTIVE
DISEASES, CHRONIC CONSTIPATION, HYPERTEN-
SION, OSTEOARTHRITIS PAIN AND SWELLING, AND
HUMAN SEXUAL DESIRE DISORDER.
FIRST USE 1-1-2002; IN COMMERCE 1-1-2002.
ELEMENTS CORRECTED
*OWNER NAME*
*OWNER ADDRESS*
*CITIZENSHIP*
*ENTITY*